2015, Number 3
<< Back Next >>
Salud Mental 2015; 38 (3)
Alucinaciones visuales en pacientes con privación sensorial: ¿síndrome de Charles Bonnet?
Negrete MY, Ramírez-Bermúdez J, Ruiz-Chow A, Aguilar-Venegas LC, Crail-Melendez D, Pérez-Esparza R, Alviso SLD
Language: Spanish
References: 54
Page: 217-224
PDF size: 506.98 Kb.
ABSTRACT
Introduction
Some patients, after brain or peripheral injuries, lose a sensory function,
such as sight or hearing, but paradoxically experience complex
hallucinations related to the function they have lost. It is known that
this phenomenon may appear with injuries at any level in the visual
pathway, especially in the retina.
Objective
To review the existent bibliography on the Charles Bonnet syndrome to
establish the state of the art with regards to this phenomenon.
Method
The databases PubMed and PsychInfo were searched for articles containing
the following keywords: Charles Bonnet syndrome; visual hallucinations;
peduncular hallucinosis; Charles Bonnet; sensory deprivation.
We included those related to the subject. We also included the
classic texts referring to this phenomenon and the articles mentioned
in the literature.
Results
In the present study, we describe the history of Charles Bonnet syndrome,
clinical presentation, risk factors, diagnostic criteria, treatment
employed, similar conditions and the theories seeking to explain it.
Discussion and conclusion
To date, the diagnostic criteria for Charles Bonnet syndrome remain
controversial, especially those concerning the absolute preservation of
insight as a sine qua non factor to establish the diagnosis. Conclusion:
Described since the 18th century, the Charles Bonnet syndrome corresponds
to the prototype of visual hallucinations in patients with visual
deprivation, although, according to the present review, its phenomenology
is vast, remaining unclear if it corresponds to the prototype of
hallucinations with preserved insight.
REFERENCES
Evers S, Ellger T. The clinical spectrum of musical hallucinations. J Neurol Sci 2004;227(1):55–65.
Flor H. Phantom-limb pain: characteristics, causes, and treatment. Lancet Neurol 2002;1(julio):182–189.
Bonnet C. Essai analytique sur les facultés de l’âme. Segunda edición. Copenhague y Ginebra: A Copenhauge, Chez les Freres Cl. & Ant. Philbert; 1775.
Berrios GE, Brook P. The Charles Bonnet Syndrome and the problem of visual perceptual disorders in the elderly. Age Ageing 1982;11:17–23.
Podoll K, Osterheider M, Noth J. The Charles Bonnet syndrome. Fortschr Neurol Psychiatr 1989;57(2):43–60.
Gilmour G, Schreiber C. An examination of the relationship between low vision and Charles Bonnet syndrome. Can J Ophthalmol 2009;44(1):49–52.
Needham WE, Taylor RE. Atypical Charles Bonnet hallucinations: an elf in the woodshed, a spirit of evil, and the cowboy malefactors. J Nerv Ment Dis 2000;188(2):108–115.
Menon G. Complex visual hallucinations in the visually impaired The Figura 1. Posibles mecanismos fisiopatológicos. Charles Bonnet Syndrome. Surv
Teunisse R. Visual hallucinations in psychologically normal people: Charles Bonnet’s syndrome. Lancet 1996;347(9004):794–797.
Teunisse RJ, Zitman FG, Raes D. Clinical evaluation of 14 patients with the Charles Bonnet syndrome (isolated visual hallucinations). Compr Psychiatry 1994;35(1):70–75.
O’Reilly R, Chamberlaine C. Charles Bonnet syndrome: incidence and demographic and clinical features. Can J Psychiatry 1996;41(4):259–260.
Hori H, Terao T, Nakamura J. Charles Bonnet syndrome with auditory hallucinations: a diagnostic dilemma. Psychopathology 2001;34(3):164– 166.
Jackson ML, Bassett KL. The natural history of the Charles Bonnet Syndrome. Do the hallucinations go away? Eye (Lond) 2010;24(7):1303–1304.
Jackson M, Bassett K, Nirmalan P. Charles Bonnet hallucinations: Natural history and risk factors. Int Congr Ser 2005;1282:592–595.
De Morsier G. Le syndrome de Charles Bonnet: hallucinactions visuelles des vieillards sans déficience mentale. Ann Med Psychol (París) 1967;125:677–702.
Lance JW. Simple formed hallucinations confined to the area of a specific visual field defect. Brain A JNeurol 1976;99(4):719-734.
Kolmel H. Complex visual hallucinations in the hemianoptic field. J Neurol Neurosurg Psychiatry 1985;48:29–38.
Weinberger L, Grant F. Visual hallucinations and their neuro-optical correlates. Arch Ophthalmol 1940;23:166–199.
Teunisse RJ, Cruysberg JR, Hoefnagels WH, et al. Social and psychological characteristics of elderly visually handicapped patients with the Charles Bonnet Syndrome. Compr Psychiatry 1999;40(4):315–319.
Holroyd S, Rabins P V, Finkelstein D, Lavrisha M. Visual hallucinations in patients from an ophthalmology clinic and medical clinic population. J Nerv Ment Dis 1994;182(5):273–276.
Holroyd S, Rabins P V, Finkelstein D et al. Visual hallucinations in patients with macular degeneration. Am J Psychiatry 1992;149(12):1701–1706.
Terao T, Collinson S. Charles Bonnet syndrome and dementia. Lance 2000;355(9221):2168.
Pliskin NH, Kiolbasa TA, Towle VL et al. Charles Bonnet syndrome: an early marker for dementia? J Am Geriatr Soc 1996;44(9):1055–1061.
Teunisse RJ, Cruysberg JR, Hoefnagels WH et al. Risk indicators for the Charles Bonnet syndrome. J Nerv Ment Dis 1998;186(3):190–192.
Tan CSH, Lim VSY, Ho DYM et al. Charles Bonnet syndrome in Asian patients in a tertiary ophthalmic centre. Br J Ophthalmol 2004;88(10):1325–1329.
Kester EM. Charles Bonnet syndrome: case presentation and literature review. Optometry 2009;80(7):360–366.
Teunisse RJ, Cruysberg J, Verbeek A, Zitman FG. The Charles Bonnet syndrome: a large prospective study in The Netherlands. A study of the prevalence of the Charles Bonnet syndrome and associated factors in 500 patients attending the University Department of Ophthalmology at Nijmegen. Br J Psychiatry 1995;166(2):254.
Schwartz TL, Vahgei L. Charles Bonnet syndrome in children. J. AAPOS Off. Publ. Am. Assoc. Pediatr. Ophthalmol. Strabismus Am Assoc Pediatr Ophthalmol Strabismus 1998;2(5):310–313.
Gold K, Rabins P V. Isolated visual hallucinations and the Charles Bonnet syndrome: a review of the literature and presentation of six cases. Compr Psychiatry 1989;30(1):90–98.
Holroyd S, Currie L, Wooten G. Prospective study of hallucinations and delusions in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2001;70(6):734–738.
Schultz G, Melzack R. Visual hallucinations and mental state. A study of 14 Charles Bonnet syndrome hallucinators. J Nerv Ment Dis 1993;181(10):639–643.
Frost EJ, Mottley JL, Edlow J. A Charles Bonnet syndrome: Three cases in the emergency department. J Emerg Med 2009;xx(x):1–3.
Teunisse RJ. Reaction on “The Charles Bonnet syndrome and dementia”. Tijdschr Psychiatr 2009;51(7):525–526.
Ramírez-Bermúdez J. Breve diccionario clínico del alma. Primera edición. México: Debate; 2010.
Paulig M, Mentrup H. Charles Bonnet’s syndrome: complete remission of complex visual hallucinations treated by gabapentin. J Neurol Neurosurg Psychiatry 2001;70(6):813–814.
Jang JW, Youn YC, Seok JW et al. Hypermetabolism in the left thalamus and right inferior temporal area on positron emission tomography- statistical parametric mapping (PET-SPM) in a patient with Charles Bonnet syndrome resolving after treatment with valproic acid. J Clin Neurosci 2011;18(8):1130–1132.
Segers K. Charles Bonnet syndrome disappearing with carbamazepine and valproic acid but not with levetiracetam. Acta Neurol Belg 2009;109(1):42-43.
Terao T. Effect of carbamazepine and clonazepam combination on Charles Bonnet syndrome: a case report. Hum Psychopharmacol Clin Exp 1998;453:451–453.
Ranen NG, Pasternak RE, Rovner BW. Cisapride in the treatment of visual hallucinations caused by vision loss: the Charles Bonnet syndrome. J Am Assoc Geriatr Psychiatry 1999;7(3):264-266.
Chen J, Gomez M, Veit S, O’Dowd M. A visual hallucinations in a blind elderly woman: Charles Bonnet syndrome, an underrecognized clinical condition. Gen Hosp Psychiatry 1996;18(6):453–455.
Coletti Moja M, Milano E, Gasverde S et al. Olanzapine therapy in hallucinatory visions related to Bonnet syndrome. Neurol Sci 2005;26(3):168–170.
Cumurcu T, Elbozan C. Charles Bonnet syndrome: a case presentation. Turkish J Psychiatry 2005;16(1):60–63.
Mocellin R. Neuropsychiatry of complex visual hallucinations. Aust N Z J Psychiatry 2006;40(9):742–751.
Howard R, Meehan O, Powell R. Successful treatment of Charles Bonnet syndrome type visual hallucinosis with low-dose risperidone. Int J 1994;9:675–678.
Maeda K, Shirayama Y, Nukina S et al. Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of 1 patient with risperidone. J Clin Psychiatry 2003;64(9):1131–1132.
Batra A, Bartels M, Wormstall H. Therapeutic options in Charles Bonnet syndrome. Acta Psychiatr Scand 1997;96(2):129-133.
Lang UE, Stogowski D, Schulze D et al. Charles Bonnet Syndrome: successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors. J Psychopharmacol 2007;21(5):553–555.
Siddiqui Z, Ramaswmay S, Petty F. Mirtazapine for Charles Bonnet syndrome. Can J Psychiatry 2004;49(11):787–788.
Ukai S, Yamamoto M, Tanaka M, Takeda M. Treatment of typical Charles Bonnet syndrome with donepezil. Int Clin Psychopharmacol 2004;19(6):355–357.
Risser AH, Powell FC. Lhermitte’s peduncular hallucinosis. En: 45th Annual Meeting of the American Academy of Neurology in New York, New York; 1993.
Kölmel HW. Peduncular hallucinations. J Neurol 1991;238(8):457–459.
Bartlet JEA. A case of organized visual hallucinations in an old man with cataract, and their relation to the phenomena of the phantom limb. Brain A J Neurol 1951;74(3):363–373.
Ffytche DH, Howard RJ, Brammer MJ et al. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci 1998;1(8):738–742.
Ossola M, Romani A, Tavazzi E et al. Epileptic mechanisms in Charles Bonnet syndrome. Epilepsy Behav 2010;18(1-2):119–122.